Association of Oseltamivir Treatment With Virus Shedding, Illness, and Household Transmission of Influenza Viruses

J Infect Dis. 2015 Aug 1;212(3):391-6. doi: 10.1093/infdis/jiv058. Epub 2015 Feb 2.

Abstract

In an observational study of 582 patients with laboratory-confirmed influenza virus infections and their household contacts, we found that the initiation of oseltamivir within 24 hours was associated with shorter duration of self-reported illness symptoms (56% reduction in duration; 95% confidence interval, 41%-67%). However, we did not find any association of oseltamivir treatment with duration of viral shedding by polymerase chain reaction or with the risk of household transmission.

Keywords: acute respiratory illness; influenza; oseltamivir.

Publication types

  • Observational Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antiviral Agents / therapeutic use*
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Influenza, Human / drug therapy*
  • Influenza, Human / transmission*
  • Influenza, Human / virology
  • Male
  • Orthomyxoviridae / drug effects
  • Orthomyxoviridae / physiology*
  • Oseltamivir / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Virus Shedding / drug effects*
  • Young Adult

Substances

  • Antiviral Agents
  • Oseltamivir